Ebba Gløersen Müller

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

Ebba Gløersen Müller, Trine Holt Edwin, Caroline Stokke et al. · PLoS ONE · 2019 · 44 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

Guri Hagberg, Hege Ihle‐Hansen, Brynjar Fure et al. · BMC Neurology · 2020 · 32 citations · Full text

Medicine, Neurology, Neuroscience +17

Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer’s disease

Ebba Gløersen Müller, Caroline Stokke, Henning Langen Stokmo et al. · Quantitative Imaging in Medicine and Surgery · 2021 · 18 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

β‐Amyloid may accumulate in the human brain after focal bacterial infection: An ¹⁸F‐flutemetamol positron emission tomography study

Ane Gretesdatter Rogne, Ebba Gløersen Müller, Eirin Udnæs et al. · European Journal of Neurology · 2020 · 13 citations · Full text

Medicine, Neurology, Neuroscience +17